Shaily Engineering Plastics Limited has reported robust financial performance for the quarter and year ended March 31, 2026. The board has recommended a final dividend of ₹3 per share (150%) for the fiscal year. Additionally, the company has approved an enabling resolution to raise up to ₹500 crore to fund its strategic transition into a diversified, IP-led global manufacturing platform serving the healthcare, consumer electronics, and semiconductor industries.
Fiscal Performance Highlights
For the financial year ended March 31, 2026, Shaily Engineering Plastics reported a strong performance with consolidated revenue of ₹99,066.72 lakh, compared to ₹78,679.77 lakh in the previous fiscal year. Net profit for the year rose significantly to ₹16,991.21 lakh, up from ₹9,311.90 lakh in the prior year. The board has recommended a final dividend of ₹3 per equity share (150% of the face value of ₹2), subject to shareholder approval.
Strategic Expansion and Capital Raising
To support its evolution into a diversified manufacturing powerhouse, the company has passed an enabling resolution to raise up to ₹500 crore. These funds are intended to drive growth across multiple high-growth, precision-intensive sectors. Shaily is actively expanding its footprint beyond traditional healthcare, having recently entered the consumer electronics market and secured a supply agreement with a Korean firm for semiconductor trays, positioning the company within the global semiconductor supply chain.
Leadership and Governance Updates
As part of its growth strategy, the company has appointed Mr. Chi Hung Kam (Mr. Joe Kam) as the Chief Operating Officer – Healthcare, effective May 20, 2026. Mr. Kam brings over 20 years of international manufacturing experience, having previously held senior leadership roles at SHL Medical and Flextronics. Additionally, the board has approved the appointment of M/s Jain & Hindocha as Internal Auditors and M/s YS Thakar & Co as Cost Auditors for the 2026-27 financial year.
Source: BSE
